Filing Details

Accession Number:
0001213900-25-060962
Form Type:
13G Filing
Publication Date:
2025-07-01 20:00:00
Filed By:
Five Narrow Lane LP
Company:
Oragenics Inc (NYSEMKT:OGEN)
Filing Date:
2025-07-02
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Five Narrow Lane LP 0 82,210 9.99%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Note to 5, 7, 9 and 11: Based on 822,927 shares outstanding as of June 23, 2025 pursuant to a Form S-1 filed on June 23, 2025 with the Securities and Exchange Commission. Note to 10: The aggregate amount in Row 9 represents the maximum amount of shares that Five Narrow Lane LP can beneficially control under a contractually stipulated 9.99% ownership restriction.


SCHEDULE 13G


 
Five Narrow Lane LP
 
Signature:/s/ Arie Rabinowitz
Name/Title:Arie Rabinowitz/Managing Member of the General Partner
Date:07/02/2025